Evidence map›Paper›PMID 23117821›Full record

ArticleTranscription

Akt1, EMSY, BRCA2 and type I IFN signaling: a novel arm of the IFN response.

Scott A Ezell, Philip N Tsichlis

Abstract read
In one paragraph

Article in Transcription. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Multiethnic genome-wide and HLA association study of total serum IgE level.The Journal of allergy and clinical immunology · 2021
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. EMSY promoted the growth and migration of ovarian cancer cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott A EzellMolecular Oncology Research Institute, Tufts Medical Center, Boston, MA, USA.
Philip N Tsichlis

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon-stimulated transcription is thought to occur mainly through the action of the JAK/STAT pathway. However, recent findings revealed an additional PI3K/Akt-dependent pathway, which contributes to the induction of a set of interferon-stimulated genes (ISGs) through the regulation of the transcriptional repressor EMSY.

Indexed as

BRCA2 ProteinHumansInterferonsNeoplasm ProteinsNuclear ProteinsProto-Oncogene Proteins c-aktRepressor ProteinsTranscription, GeneticBRCA2 ProteinEMSY protein, humanInterferonsNeoplasm ProteinsNuclear ProteinsProto-Oncogene Proteins c-aktRepressor ProteinsAktBRCA2EMSYinterferon-stimulated gene (ISG)IRF9ISREJAK/STAT pathway

Identifiers

PMID23117821
PMCPMC3630186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.